500126 Stock Overview
Engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Procter & Gamble Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹5,117.55 |
| 52 Week High | ₹5,835.95 |
| 52 Week Low | ₹4,640.30 |
| Beta | 0.52 |
| 1 Month Change | -1.40% |
| 3 Month Change | -7.51% |
| 1 Year Change | 3.07% |
| 3 Year Change | -2.60% |
| 5 Year Change | 18.94% |
| Change since IPO | 124,414.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| 500126 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -5.8% | 1.7% | 0.2% |
| 1Y | 3.1% | 39.1% | 17.2% |
Return vs Industry: 500126 underperformed the Indian Pharmaceuticals industry which returned 39.1% over the past year.
Return vs Market: 500126 underperformed the Indian Market which returned 17.2% over the past year.
Price Volatility
| 500126 volatility | |
|---|---|
| 500126 Average Weekly Movement | 4.1% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: 500126 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 500126's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 1,336 | Milind Thatte | www.pghealthindia.com |
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands.
Procter & Gamble Health Limited Fundamentals Summary
| 500126 fundamental statistics | |
|---|---|
| Market cap | ₹84.95b |
| Earnings (TTM) | ₹2.18b |
| Revenue (TTM) | ₹11.60b |
39.0x
P/E Ratio7.3x
P/S RatioIs 500126 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 500126 income statement (TTM) | |
|---|---|
| Revenue | ₹11.60b |
| Cost of Revenue | ₹3.31b |
| Gross Profit | ₹8.28b |
| Other Expenses | ₹6.11b |
| Earnings | ₹2.18b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
| Earnings per share (EPS) | 131.17 |
| Gross Margin | 71.42% |
| Net Profit Margin | 18.77% |
| Debt/Equity Ratio | 1.8% |
How did 500126 perform over the long term?
See historical performance and comparisonDividends
2.3%
Current Dividend Yield91%
Payout RatioDoes 500126 pay a reliable dividends?
See 500126 dividend history and benchmarks| Procter & Gamble Health dividend dates | |
|---|---|
| Ex Dividend Date | Nov 28 2024 |
| Dividend Pay Date | Jan 04 2025 |
| Days until Ex dividend | 33 days |
| Days until Dividend pay date | 4 days |
Does 500126 pay a reliable dividends?
See 500126 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 20:07 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Procter & Gamble Health Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rohit Bhat | Batlivala & Karani Securities India Pvt. Ltd. |
| Ranjit Kapadia | Centrum Broking Limited |
| Anil Burra | FirstCall Research |